NCT06172296 2026-04-14
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
National Cancer Institute (NCI)
Phase 3 Recruiting
Clinical Trials
9 trialsNCT07502287 2026-03-30
DUAL-NK-NB
Beijing Biotech
Phase 1/2 Recruiting
NCT03126916 2026-02-27
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Children's Oncology Group
Phase 3 Recruiting
NCT07375563 2026-01-29
NB-NK-2026
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3 Recruiting
NCT02112617 2025-12-30
Phase II Study of Proton Radiation Therapy for Neuroblastoma
Massachusetts General Hospital
Phase NA Recruiting
NCT05192980 2025-07-22
BIOPORTAL
Institut Curie
Phase NA Recruiting
NCT03088020 2024-08-09
International Congenital Central Hypoventilation Syndrome (CCHS) Registry and CCHS SHARE
Ann & Robert H Lurie Children's Hospital of Chicago
Recruiting
NCT06296732 2024-05-20
ANLAP-R
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Recruiting
NCT06071897 2023-10-10
Induction Chemoimmunotherapy for Patients With High-risk Neuroblastoma
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
Phase 3 Recruiting